Biotech entity
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Animal Testing, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.8 across the same-window beat baseline.
Last mentioned: Mar 20, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Animal Testing, the most common co-covered peer. Source depth averages 2 original sources per story, versus 2.8 across the same-window beat baseline. The 6 average consequence score is below the beat benchmark of 6.4 in the same window. We currently track 1 Biotech story that mention Organ-on-a-chip, all published on March 20, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Organ-on-a-chip. Shared-story counts are live from our verified record — not editorial picks.
Hybrid Submission Standards
Expected formalization of regulatory pathways that prioritize NAM data over animal data for specific drug classes.
OOC Commercialization
Widespread adoption of organ-on-a-chip systems in early-stage pharmaceutical R&D for toxicity screening.
EU Regulatory Shift
The European Parliament and EMA accelerate roadmaps for the phase-out of animal use in regulatory testing.
FDA Modernization Act 2.0
President Biden signs legislation removing the requirement for animal testing for biosimilars and new drugs.
The pharmaceutical industry is navigating a historic shift as the FDA Modernization Act 2.0 removes the mandate for animal testing in drug development. However, while technologies like organ-on-a-chip and AI offer higher human predictivity, they currently lack the systemic complexity required to fully replace animal models in late-stage safety assessments.
Organ-on-a-chip is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
